On June 1, Waldencast announced that it has entered into a definitive agreement to sell its dermatological skincare and aesthetics business, Obagi Medical, to private investment firm Bridgepoint.
On June 1, Waldencast announced that it has entered into a definitive agreement to sell its dermatological skincare and aesthetics business, Obagi Medical, to private investment firm Bridgepoint.
Global Fashion, Beauty & Luxury Business Media Platform